EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS059-03960 
Organism
Homo sapiens 
Tissue/cell
GM12878 
Coordinate
chr1:207506090-207508070 
TF binding sites/motifs
Number: 12             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr1:207506892-207506910GGAAGGAAGCAAGAAAAT+6.36
IRF1MA0050.2chr1:207507255-207507276TAGGAAAAAGAGAAAGTGAGA-6.04
IRF1MA0050.2chr1:207507261-207507282AAAGAGAAAGTGAGACAAAAA-6.76
IRF8MA0652.1chr1:207506752-207506766CTGAAACTGAAACC+6.49
IRF9MA0653.1chr1:207506751-207506766ACTGAAACTGAAACC+6.51
Stat4MA0518.1chr1:207506301-207506315CTTCTAGGAAAGAG+6.05
ZNF263MA0528.1chr1:207507297-207507318GGAGGAGGAGAAGAGAAATAG+6
ZNF263MA0528.1chr1:207507279-207507300AAAGGAAGAGGGGAAGGAGGA+7.51
ZNF263MA0528.1chr1:207507282-207507303GGAAGAGGGGAAGGAGGAGGA+7.66
ZNF263MA0528.1chr1:207507288-207507309GGGGAAGGAGGAGGAGGAGAA+7.74
ZNF263MA0528.1chr1:207507294-207507315GGAGGAGGAGGAGAAGAGAAA+8.33
ZNF263MA0528.1chr1:207507291-207507312GAAGGAGGAGGAGGAGAAGAG+8.81
Number of super-enhancer constituents: 5             
IDCoordinateTissue/cell
SE_09764chr1:207505576-207511782CD14
SE_10308chr1:207505603-207512105CD19_Primary
SE_11062chr1:207489671-207513860CD20
SE_34743chr1:207505848-207507682HeLa
SE_62994chr1:207471414-207511884Tonsil
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr1207506396207507500
chr1207506165207506341
Number: 1             
IDChromosomeStartEnd
GH01I207333chr1207506346207511768
Enhancer Sequence
AAAACGACTA TAAAATCTCA ATAGATTACC AAAAAATTAT ATTTTTTAAG GCATAAGATA 60
CAGCTGTGGA AGCAACAAGG TCTGAATGAA CTAAAATTCC TGGGGGCAGG TGGTGAAGGC 120
AACCCATCCT GATGTAAGGC AGTTTTCCCT AGGGACCTTT GCTGATTCTG AACCTGGACT 180
AAGGATTCAC CTTGACCCAG ACAAAAGACC ACTTCTAGGA AAGAGAAACC AGCAAAGCTT 240
TAATGGTTAT GGAGGGATAG GGTAATACAC TGGAAATTGA GGCCCTCAAA TGCAGAACCA 300
ATTTTTCCTA AAGGCCATTT GCAAATTTTG GGGCTGCATG TGAGGCTGGG AAGGTTGACC 360
CAGAGCTTCT AAAGTACAAA ATGAAATCTC TCAGAACCTG ATGGTATTTG GATAGCATAT 420
ACCCACCAGA GGAACAGGCT TTTATCTAGC ATACCACAGG TCTCCCCTTT AGCACATCTG 480
TGCTCATTTT GAAACTGTAT AGGGAAGGAC ATTAGGTGGC TGGGAGAACT CTGAAGGACA 540
GACCTGGATC TCCTGCCACC TTCCAAAGGT GAAACAACAA AAATCCGCCA GGCTTTCAGT 600
CAGAAGCCCG GAAGGGCCAC TCCCAAGGAA CAGAGGCAAG AGCAGAAGTA GATGGAGTCT 660
TACTGAAACT GAAACCCAGC TCAATTCCTA ATAGGTTGAA GATATGATTA CCTCAATGCA 720
GTCTGCTTAT CAGAAAGGCA TATCATATCA TCCGGATGGT TTATATACAA TGTTTGGCAT 780
ACAACAAAAG ACTGTTAGAT ATGGAAGGAA GCAAGAAAAT GTGACCAAAT CAAGAGAAAA 840
CAAAACCAAA TAAAGAATAT CCAGATAATT GAGTTAGCAA ATGAGAACCT TAAAATAACT 900
GATTAACAAG TTTAAGATGA TAAAAGAAAA GAGAACTTCA GTTGGAATCT GCAAAAATGG 960
TGTAAAATGA ATATTCTACA ACTGGAAAAT ATCTGAAATT AAGAACACAA TAGATAGGTT 1020
TAGCTATTCA GGCAGAGCAG GAAACAGTAT TAGGAACTGA AAGATCGGTT AAAAATACCC 1080
AAACTGATGC ACAAAGAGAA AAAGGAATGT GAAATATAGA TAAAAGTTTG AGACATTTGA 1140
GACATGTTAA ACTGTGCTAA CACATTAGGA AAAAGAGAAA GTGAGACAAA AAGGAAGAGG 1200
GGAAGGAGGA GGAGGAGAAG AGAAATAGGA GCAGAAGAAA TATTTAAAAT GATACTTACT 1260
CAGAATTTTC CAAAACTGAT AAAGTACATT AGCCAACAGA TTCAAGAAGC TCTCTGACTC 1320
TAAGCTGAAT AAAAATAAAA CCACTTTAGC AAAAAATCTA ACTCTAAGCT GAACAAAAAT 1380
AAAACCACTC GTAGCAAAAA CAAACAACAA AAACTTCAAA GAAGCAACAG TATAACTGAT 1440
TACTGCTCAG CAAAAAATGA TGCAAACCAA AAGACAATAA GAAGAAATCT TTAAAATACT 1500
GTAAGAAAAT TACTGTTCAC CTAGAATTTT ATACCCAGTT AATATATCCT TCAAAACTGA 1560
ATGCAAAATA GAGATGTATT CAGACAAAAA CCAAGAAAAC TTTGCACTAG CAGACCAAAC 1620
ATGCACAGAA TGAGAAACTA AAGGAAATTC TTCAAGTAGA ATGAAAATAA TGCCAGGTAA 1680
AACATGAAAA TACAAAAGGA AATGAACAGT GACAAGGATA AATGAATACT GAGTTTACAA 1740
ACAGTGAATG TAATGTCCTG TGGGGTCTGA ATTATACATA GAATACAAAT GCACAATAAC 1800
AATGCGAAAG GCAGAAAGAG GTAAATTCAT TTAAAGGTTA CACAGTTCTA GCAGTACTGA 1860
AAAGGTGGTA AAAGTGATAG TTTGCATAAT TGACTTATAG TCTAATAAAT ATTGTGATCT 1920
CTAGGGTTGC TACAAATGAA TGACAGAAGA ATACATAAAT CACAAGCTAA TAAAAGAATA 1980